Estrogen replacement therapy is associated with less progression of subclinical structural brain disease in normal elderly women: a pilot study.
Cortical atrophy, central atrophy, deep white-matter hyperintensities, and periventricular hyperintensities are reported in normal aging. We examined the effects of estrogen replacement therapy (ERT) on these forms of 'subclinical structural brain disease' (SSBD) in normal, postmenopausal women in a pilot, naturalistic, longitudinal study of 15 subjects. Two assessments were performed at least two years apart, with volumetric magnetic resonance imaging (MRI) and neuropsychological testing. Women receiving open-label ERT showed significantly less progression of SSBD than those who did not. The association between reduced SSBD progression and ERT suggests this intervention could help preserve normal brain structure in healthy elderly women.